HI
TEVA icon

Hudock Inc’s Teva Pharmaceuticals TEVA Stock Holding History

Hudock Inc’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-100
Closed – – 792
2020
Q3 		$0 Hold
100
– – ﹤0.01% 785
2020
Q2 		$1K Sell
100
-1,225
-92% -$13.9K ﹤0.01% 707
2020
Q1 		$11K Buy
1,325
+1,225
+1,225% +$12.6K ﹤0.01% 392
2019
Q4 		$0 Sell
100
-100
-50% -$893 ﹤0.01% 721
2019
Q3 		$1K Sell
200
-300
-60% -$2.3K ﹤0.01% 673
2019
Q2 		$4K Hold
500
– – ﹤0.01% 540
2019
Q1 		$7K Sell
500
-100
-17% -$1.76K ﹤0.01% 449
2018
Q4 		$9K Hold
600
– – ﹤0.01% 409
2018
Q3 		$12K Sell
600
-135
-18% -$3.13K ﹤0.01% 409
2018
Q2 		$17K Sell
735
-31
-4% -$632 0.01% 365
2018
Q1 		$13K Sell
766
-1,532
-67% -$29.9K 0.01% 413
2017
Q4 		$43K Sell
2,298
-593
-21% -$8.92K 0.02% 253
2017
Q3 		$50K Buy
2,891
+164
+6% +$3.69K 0.02% 237
2017
Q2 		$90K Buy
2,727
+540
+25% +$16.7K 0.05% 155
2017
Q1 		$70K Buy
2,187
+116
+6% +$3.96K 0.04% 178
2016
Q4 		$75K Buy
2,071
+7
+0.3% +$279 0.04% 173
2016
Q3 		$94K Hold
2,064
– – 0.05% 149
2016
Q2 		$103K Buy
2,064
+564
+38% +$30K 0.06% 142
2016
Q1 		$80K Buy
1,500
+1,000
+200% +$58.7K 0.04% 170
2015
Q4 		$32K Hold
500
– – 0.01% 259
2015
Q3 		$28K Hold
500
– – 0.01% 278
2015
Q2 		$29K Hold
500
– – 0.01% 284
2015
Q1 		$31K Hold
500
– – 0.01% 286
2014
Q4 		$29K Sell
500
-100
-17% -$5.57K 0.01% 268
2014
Q3 		$32K Sell
600
-1,500
-71% -$79.5K 0.02% 262
2014
Q2 		$110K Hold
2,100
– – 0.13% 123
2014
Q1 		$111K Hold
2,100
– – 0.09% 119
2013
Q4 		$84K Hold
2,100
– – 0.07% 135
2013
Q3 		$79K Hold
2,100
– – 0.08% 128
2013
Q2 		$82K Buy
+2,100
New +$81.8K 0.12% 124

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Berkshire Hathaway
Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return

Hudock Inc's TEVA Position: Q4 2020 in Review

Hudock Inc sold out of Teva Pharmaceuticals (TEVA) in Q4 2020, closing a stake of 100 shares.

Hudock Inc first reported a position in TEVA in Q2 2013 and held it in 30 quarters. The position peaked at $111K in Q1 2014. 449 funds tracked by Wall St. Rank hold TEVA as of Q4 2020.

  • Hudock Inc reported no remaining Teva Pharmaceuticals position as of Q4 2020 after selling out during the quarter.
  • Hudock Inc sold 100 Teva Pharmaceuticals shares in Q4 2020.
  • Hudock Inc first reported a position in Teva Pharmaceuticals in Q2 2013 and held it in 30 quarters.
  • Hudock Inc's Teva Pharmaceuticals position peaked at $111K in Q1 2014.
  • 449 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q4 2020.

Based on Hudock Inc's 13F filing for Q4 2020, filed 5 Feb 2021.